ICD-10 Coding for Amyloidosis(E85.81, E85.81A, E85.81B)
Explore detailed ICD-10 coding guidelines for amyloidosis, including AL and ATTR types. Learn about documentation requirements and common coding pitfalls.
Complete code families applicable to Amyloidosis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| E85.81 | AL amyloidosis | Use when AL amyloidosis is confirmed with organ involvement. |
|
| E85.82 | Hereditary ATTR amyloidosis | Use for confirmed ATTR amyloidosis with genetic testing. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAmyloidosis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Amyloidosis.
Omitting organ involvement in documentation
Impact
Clinical: Inadequate treatment planning., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials.
Mitigation
Use templates to ensure all elements are documented., Regular training on documentation standards.
Using E85.9 when subtype is known
Impact
Reimbursement: Incorrect coding can lead to claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Poor data quality affecting patient records.
Mitigation
Always specify the subtype of amyloidosis when known.
Specificity of coding
Impact
Audits may target incorrect use of unspecified codes when specific types are documented.
Mitigation
Ensure all documentation specifies the type and organ involvement.